COFCO Biotechnology Co., Ltd.
Symbol: 000930.SZ
SHZ
6.57
CNYTržní cena dnes
-21.1266
Poměr P/E
-2.7465
Poměr PEG
12.13B
MRK Cap
- 0.09%
Výnos DIV
COFCO Biotechnology Co., Ltd. (000930-SZ) finanční výkazy
Rozvaha
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1481.1 | 1016.6 | 1116 | ||||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 2.1 | 3.8 | -24.4 | ||||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 1549.6 | 2608.5 | 2147 | ||||||||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 2534.3 | 3763.2 | 4052.3 | ||||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 470.3 | 282.6 | 319.1 | ||||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 6035.3 | 7671 | 7634.4 | ||||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 8678 | 8612 | 8650 | ||||||||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 366 | 366 | 366 | ||||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 602.7 | 610.6 | 629.7 | ||||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 968.7 | 976.6 | 995.8 | ||||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 535.4 | 536.9 | 536.6 | ||||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 265 | 164.5 | 202.8 | ||||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 75.5 | 139.2 | 42.6 | ||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 10522.5 | 10429.3 | 10427.7 | ||||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 16557.9 | 18100.3 | 18062.1 | ||||||||||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 681.9 | 919.6 | 920.2 | ||||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 3398.9 | 2929.1 | 2871.7 | ||||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 47.6 | 91.4 | 64.5 | ||||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 165.6 | 296.9 | 523.7 | ||||||||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 56.5 | 59 | 50.9 | ||||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 794.7 | 1034.1 | 32.4 | ||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 492.5 | 427.3 | 712.9 | ||||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 196.6 | 105.6 | 117.3 | ||||||||||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 5634.3 | 5588.8 | 6303.4 | ||||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 1864.7 | 1865.3 | 1865.7 | ||||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 1411.7 | 3152.3 | 2601.3 | ||||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 1226.6 | 1131.5 | 989.9 | ||||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 5948.5 | 5950.8 | 5940.4 | ||||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 10451.6 | 12099.9 | 11397.4 | ||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 16557.9 | 18100.3 | 18062.1 | ||||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 402 | 411.6 | 361.3 | ||||||||||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 10853.6 | 12511.5 | 11758.7 | ||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||||||||||||
Total Investments | 0 | 535.4 | 536.9 | 512.1 | ||||||||||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 3761.1 | 3226 | 3395.4 | ||||||||||||||||||||||||||||
balance-sheet.row.net-debt | 0 | 2280 | 2209.4 | 2279.5 |
Výkaz peněžních toků
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 1060.9 | 1133 | 628.2 | |||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 458.2 | 446.3 | 436.4 | |||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 36.1 | -62.2 | -3.3 | |||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -5 | 62.2 | 3.3 | |||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -1261.9 | 2701.8 | -4471.1 | |||||||||||||||||||||||||
cash-flows.row.account-receivables | 0 | -1051.9 | 2418.2 | -2276.3 | |||||||||||||||||||||||||
cash-flows.row.inventory | 0 | 83.1 | 760.3 | -2462.3 | |||||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -329.1 | -414.5 | 270.7 | |||||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 36.1 | -62.2 | -3.3 | |||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 420.1 | 560.4 | 495.7 | |||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -565.8 | -1109.8 | -987.5 | |||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 305.7 | 160.5 | 107.8 | |||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -32.6 | 270.4 | -21.1 | |||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 14.8 | 1.6 | 6.3 | |||||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | -22.7 | 9.4 | -4.5 | |||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -300.6 | -667.9 | -899 | |||||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -6493.2 | -11592.7 | -5566.1 | |||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -554.7 | -277.3 | -164.4 | |||||||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 6453.7 | 8168.4 | 9485.1 | |||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -594.3 | -3701.7 | 3754.6 | |||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 40.4 | -4.3 | -0.5 | |||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -146.1 | 467.7 | -55.8 | |||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 963 | 1109.1 | 641.4 | |||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1109.1 | 641.4 | 697.2 | |||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 708.4 | 4841.6 | -2910.9 | |||||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -565.8 | -1109.8 | -987.5 | |||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 142.7 | 3731.8 | -3898.4 |
Řádek výkazu zisku a ztráty
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 20289.8 | 19918.1 | 23468.6 | ||||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 19341.4 | 17666.6 | 20842.8 | ||||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 948.4 | 2251.5 | 2625.7 | ||||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | -534.2 | 75 | 259 | ||||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 1403.8 | 553.1 | 752.6 | ||||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 20745.3 | 18219.7 | 21595.5 | ||||||||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 16.2 | 16.2 | 15.4 | ||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 112.8 | 87.1 | 157.8 | ||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -84.2 | 9.7 | -543.5 | ||||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -534.2 | 75 | 259 | ||||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -84.2 | 9.7 | -543.5 | ||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 112.8 | 87.1 | 157.8 | ||||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 509.2 | 888.7 | 446.3 | ||||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||||||||||||||
income-statement-row.row.operating-income | 0 | -455.4 | 1350.2 | 1926.6 | ||||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -539.7 | 1359.9 | 1383.1 | ||||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 73.8 | 298.9 | 250.1 | ||||||||||||||||||||||||||||
income-statement-row.row.net-income | 0 | -601.6 | 1058.5 | 1129.6 |
Často kladené otázky
Co je COFCO Biotechnology Co., Ltd. (000930.SZ) celková aktiva?
COFCO Biotechnology Co., Ltd. (000930.SZ) celková aktiva jsou 16557861385.000.
Jaký je roční obrat podniku?
Roční příjmy jsou N/A.
Jaké je ziskové rozpětí podniku?
Zisková marže firmy je 0.056.
Jaký je volný peněžní tok podniku?
Volný peněžní tok je 1.426.
Jaká je čistá zisková marže podniku?
Čistá zisková marže je -0.028.
Jaké jsou celkové tržby podniku?
Celkové příjmy jsou -0.025.
Co je COFCO Biotechnology Co., Ltd. (000930.SZ) čistý zisk (čistý příjem)?
Čistý zisk (čistý příjem) je -601629843.000.
Jaký je celkový dluh podniku?
Celkový dluh je 3761143669.000.
Jaké je číslo provozních nákladů?
Provozní výdaje jsou 1403828205.000.
Jaké je číslo peněžních prostředků firmy?
Peněžní prostředky podniku jsou 0.000.